CLC Bio said this week that it has appointed Richard Lussier as director of business for the Americas region. He has worked in life sciences sales and commercial operations, most recently as VP of worldwide sales at RainDance Technologies. He formerly held leadership positions in sales, service, and support at Solexa, Fluidigm, Applied Biosystems, and Celera Genomics.
NanoString said this week that it has hired Bruce Seeley to lead a new diagnostics business unit. In his position as senior vice president and general manager of diagnostics, Seeley will oversee the marketing of NanoString's breast cancer test to pathologists and oncologists. Seeley previously was executive VP of Seattle Genetics' commercial operations, he was senior director of marketing at Genentech, and he worked at Aventis Pharma as senior director of new product commercialization and marketing. He also held sales and marketing titles at Rhone-Poulenc Rorer and Bristol-Myers Squibb.
IntegenX has appointed David Smith to serve as its new COO. Smith most recently served as CFO of Thoratec, and previous to that was CFO at Chiron. He currently is chair of the audit committee and a director of OncoGenex Pharmaceuticals and previously was chair of the audit committee and a director of Perlegen Sciences.
Read more from the original source:
Deal with Bariatric Support Brings GenoVive's DNA-based Weight Loss Program to Mexico
